Richard van den Broek

Insider Reports History

Location
Greenwich, CT
Signature
/s/ Kenneth B. Stratton, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard van den Broek:

Company Role Class Num Shares Value Price $ Report Date Ownership
Corvus Pharmaceuticals, Inc. Director Common Stock 160,000 08 Apr 2025 Indirect
Corvus Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 30,000 08 Apr 2025 Direct
PULSE BIOSCIENCES, INC. Director Stock Option (right to buy) 30,000 15 Aug 2025 Direct
PhaseBio Pharmaceuticals Inc Director Non-employee Director Stock Option (right to buy) 17,500 19 May 2022 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 0 19 May 2023 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 19 May 2023 Direct

Insider Reports Filed by Richard van den Broek

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLSE PULSE BIOSCIENCES, INC. 15 Aug 2025 1 $0 4 Director 19 Aug 2025, 21:38
CRVS Corvus Pharmaceuticals, Inc. 08 Apr 2025 1 $0 4 Director 09 Apr 2025, 17:26
CRVS Corvus Pharmaceuticals, Inc. 08 Apr 2025 0 $0 3 Director 09 Apr 2025, 17:26
PLSE Pulse Biosciences, Inc. 06 Jun 2024 2 $0 4 Director 24 Jun 2024, 19:38
PLSE Pulse Biosciences, Inc. 25 May 2023 2 $0 4 Director 06 Jun 2023, 19:25
/report/000116924523000033-van-den-broek-richard-2023-05-19 PhaseBio Pharmaceuticals Inc 19 May 2023 2 $0 4 Director 19 May 2023, 16:18
PLSE Pulse Biosciences, Inc. 19 May 2022 2 $0 4 Director 23 May 2022, 20:54
/report/000116924522000060-van-den-broek-richard-2022-05-19 PhaseBio Pharmaceuticals Inc 19 May 2022 2 $0 4 Director 20 May 2022, 16:44
/report/000116924521000065-van-den-broek-richard-2021-06-03 PhaseBio Pharmaceuticals Inc 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 18:17
PLSE Pulse Biosciences, Inc. 20 May 2021 2 $0 4 Director 21 May 2021, 17:08